Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy‘s cash ...
Opinion

backed stablecoin brings little gain, but it puts stability and bank deposits at considerable risk

India is considering regulating rupee-backed stablecoins. This move follows growing demand and concerns about financial stability. Two firms are developing India's first rupee-backed stablecoin for a ...